Raymond James engaged as financial advisorReduction in force implemented NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that it has retained Raymond James & Associates, Inc. to serve as exclusive financial advisor to assist the company in its previously announced exploration of strategic alternatives. The company also announced that it is impleme ...

Financial Performance - Sierra Bancorp declared a regular quarterly cash dividend of $0.26 per share, marking a 4% increase from the previous quarter's dividend of $0.25 per share [1] - The dividend will be paid on February 17, 2026, to shareholders of record as of February 9, 2026 [1] - The company has paid regular cash dividends every year since 1987, with the current announcement representing the 108th consecutive quarterly cash dividend [1] Company Overview - Sierra Bancorp is the parent company of Bank of the Sierra, which is one of the largest independent banks in the South San Joaquin Valley [2] - Bank of the Sierra offers a wide range of retail and commercial banking services through full-service branches in several counties, including Tulare, Kern, Kings, Fresno, Ventura, San Luis Obispo, and Santa Barbara [2] - In 2025, Bank of the Sierra was recognized as one of the strongest community banks in the country, receiving a 5-star rating from Bauer Financial [2]

ZEELAND, Mich., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today reported financial results for the fourth quarter and calendar year ended December 31, 2025. Fourth Quarter and Calendar Year 2025 Highlights: Fourth Quarter 2025 Net Sales: Consolidated $644.4 million; Core Gentex (ex-VOXX) $541.0 millionGross Margin: Consolidated 34.8%; Core G ...

Core Viewpoint - First Hawaiian, Inc. reported strong financial results for the fourth quarter of 2025, highlighting growth in loans and deposits, and maintaining its position as the most profitable bank in Hawaii [1][12]. Financial Performance - Net income for the fourth quarter of 2025 was $69.9 million, or $0.56 per diluted share, compared to $73.8 million in the prior quarter [12][27]. - Net interest income increased to $170.3 million, up by $1.0 million from the previous quarter, with a net interest margin of 3.21%, an increase of 2 basis points [5][12]. - Noninterest income was $55.6 million, a decrease of $1.5 million from the prior quarter [7][12]. - Noninterest expense decreased slightly to $125.1 million from $125.7 million in the previous quarter, resulting in an efficiency ratio of 55.1% [8][12]. Balance Sheet Highlights - Total assets were $24.0 billion as of December 31, 2025, down from $24.1 billion at the end of the previous quarter [4][12]. - Gross loans and leases increased to $14.3 billion, up by $183.1 million from the prior quarter [4][12]. - Total deposits decreased to $20.5 billion, down by $213.9 million from the previous quarter [4][12]. - Total stockholders' equity rose to $2.8 billion, compared to $2.7 billion at the end of the previous quarter [11][12]. Credit Quality - The allowance for credit losses was $168.5 million, or 1.18% of total loans and leases, compared to $165.3 million, or 1.17%, in the prior quarter [10][12]. - Net charge-offs for the quarter were $5.0 million, or 0.14% of average loans and leases, compared to $4.2 million, or 0.12%, in the previous quarter [10][12]. Capital Management - The Board of Directors declared a quarterly cash dividend of $0.26 per share, payable on February 27, 2026 [1][12]. - A stock repurchase program was adopted for up to $250.0 million of outstanding common stock [2][12]. - The company repurchased approximately 1.0 million shares at a total cost of $26.0 million during the fourth quarter [13][12]. Taxation - The effective tax rate for the fourth quarter was 24.8%, up from 23.2% in the prior quarter [9][12].

PARAMUS, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), today announced that shares of the Company’s common stock have been approved for listing on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “PLYX”. Shares of Polaryx common stock are expected to commence ...

BELVIDERE, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce,  today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-10. The reverse stock split will take effect as of 12:01 a.m. ET, on February 3, 2026, and shares of Edible Garden will trade on a post-split basis on Nasdaq ...

The Sonoma by LGI Homes at Monte Vista Collection The five-bedroom, three-bath Sonoma features flexible living and open entertainment space. SHAFTER, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) announced the upcoming release of its newest community in the Modesto, California area, Monte Vista Collection. Monte Vista Collection offers homebuyers exceptional value for a newly constructed home in a peaceful, family-friendly neighborhood. Monte Vista Collection is located near T ...

Core Viewpoint - Horizon Space Acquisition II Corp. has postponed its extraordinary general meeting to allow more time for shareholder engagement [1] Group 1: Meeting Details - The extraordinary general meeting is rescheduled from February 3, 2026, to February 12, 2026, at 9:00 a.m. Eastern Time [1] - The location of the meeting remains unchanged at Robinson & Cole LLP, New York, and it will also be available via teleconference [2] - The record date for shareholders entitled to vote remains December 29, 2025, and shareholders can vote even if they have sold their shares [2] Group 2: Shareholder Actions - The deadline for public shareholders to submit redemption requests is extended to February 10, 2026, at 5:00 p.m. Eastern Time due to the postponement [2] - Shareholders who have already voted do not need to take any action if they do not wish to change their vote [2] Group 3: Contact Information - Shareholders with questions regarding the postponement or voting can contact VStock Transfer, LLC or Advantage Proxy, Inc. for assistance [3]

Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential.Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy directly targeting the OX40 receptor expressed on pathogenic T-cells shows potential to deliver long-term disease control in patients with moderate-to-severe atopic dermatitis (msAD).Regulatory submission is planned in the first half of 2026. TOKYO and PRINCETON, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) ...

KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced a potential expansion of its exosome-related pipeline beyond its previously disclosed CELESOME(+) program. The announcement follows the publication of a preliminary retrospective clinical case seri ...